home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Alzheimer's Vaccine Reviewed

 
  November, 29 2005 11:43
your information resource in human molecular genetics
 
     
A controversial vaccine that was the subject of a halted trial to prevent cognitive decline in Alzheimer's patients could have the potential to be reformulated to eliminate its toxicity while retaining the benefits. In a Practice Point article in the December issue of Nature Clinical Practice Neurology, Thomas Wisniewski considers how this could be achieved, while commenting on the recently published trial results.

Despite evidence that an amyloid beta vaccine can reduce brain amyloid deposits and improve cognitive function in patients with Alzheimer's disease, the clinical trial was stopped owing to the development of encephalitis in a small proportion of patients. Wisniewski points out that the positive and negative effects of the vaccine are attributable to different components of the immune response. Improvements in cognitive function were linked to an antibody-mediated response, whereas encephalitis was associated with a cell-mediated response. Antibodies that are engineered to avoid the cell-mediated response while retaining the antibody-mediated response could be the way forward, he argues.

The ability to image amyloid plaques in the living brain is important both for the diagnosis of Alzheimer's disease and for increasing our knowledge of the underlying disease mechanisms. In a Technology Insight Review article, Dan Huddleston and Scott Small review recent progress using positron emission tomography (PET scanning) in humans, and consider whether some promising results using magnetic resonance imaging in animals might be translated into the clinical setting.

Author contact details:

Thomas Wisniewski (New York University School of Medicine, New York, NY, USA)
Email: thomas.wisniewski@med.nyu.edu

Scott A Small (Columbia University College of Physicians and Surgeons, New York, NY, USA)
Email: sas68@columbia.edu

Free full text articles available online:
WISNIEWSKI Article;
SMALL Article.

(C) Nature Clinical Practice Neurology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.